Drew Watson

Drew Watson's Title

Drew Watson serves as the Senior Vice President (Sr. VP) of Clinical Studies & Biostatistics. In this role, he oversees the design, execution, and analysis of clinical trials, ensuring they meet the highest standards of scientific rigor and regulatory compliance. His leadership extends to the development of statistical methodologies that drive the interpretation of complex data, crucial for advancing medical research and patient care.

Drew Watson's Education and Expertise

Drew Watson's academic background is a testament to his expertise in biostatistics and strategic management. He holds a B.S. in Statistics from California State University East Bay, an M.S. in Computational Statistics from Stanford University, and an M.B.A. in Strategic Management from Golden State University. Additionally, he earned a PhD in Biostatistics from the University of California, Los Angeles (UCLA). This extensive educational foundation equips him with a deep understanding of statistical modeling, computational techniques, and strategic decision-making, essential for leading cutting-edge clinical research.

Drew Watson's Background

Drew Watson has built a distinguished career in the biotechnology and pharmaceutical industries, having worked at prominent companies such as Invitae, Genomic Health, Incyte Genomics, and Chiron Corporation. His experience spans various roles where he contributed significantly to clinical research and biostatistics. Notably, his work at Genomic Health, where he led the pivotal clinical trial for Oncotype DX, a molecular diagnostic test for breast cancer recurrence risk assessment, showcased his ability to translate scientific discoveries into clinically actionable tests.

Drew Watson's Achievements

Drew Watson has achieved several significant milestones in his career. One of his most notable accomplishments is leading the pivotal clinical trial for Oncotype DX, which ultimately secured coverage by the Centers for Medicare and Medicaid Services (CMS). This achievement underscores his expertise in clinical trials and his impact on personalized medicine. Furthermore, he has published extensively in peer-reviewed journals, contributing valuable insights into biostatistics, oncology, and genomics. Watson also holds multiple key U.S. patents in genomics, algorithm development, and personalized medicine, highlighting his innovative contributions to the field.